The renoprotective effects of Ursodeoxycholic acid in patients with type 1 diabetes and macroalbuminuria

Trial Profile

The renoprotective effects of Ursodeoxycholic acid in patients with type 1 diabetes and macroalbuminuria

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Ursodeoxycholic acid (Primary)
  • Indications Proteinuria; Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms URSO
  • Most Recent Events

    • 28 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top